Tissues with high SOD levels and low NQO1 expression may have decreased clearance of superoxide anion, generating other check details reactive species and worsening liver injury [47]. In this study, Keap1/Nrf2 were assessed in animals with PL and advanced HCC. There is doubt as to whether Nrf2 is a tumor suppressor or oncogenic [48]. Under basal conditions, Nrf2 is sequestered in the cytoplasm by Keap1, but

induction of oxidative stress is able to dissociate Nrf2 from Keap1, leading to its translocation to the nucleus and subsequent increase on antioxidant genes expression [49]. We observed that animals in late-stage (advanced) HCC showed Keap1 overexpression and Nrf2 downregulation compared to animals in the PL group. It is known that the Nrf2 system could be induced by chemical carcinogens [50]. Activation of this factor facilitates cytoprotection and contributes to the proliferation and survival of tumor cells, whereas its inhibition results in degradation [51] and [52], allowing an increase in ROS

attacks to the cell. The role of Nrf2 is dependent on the stage of carcinogenesis. In the inflammatory phase, with precancerous lesions, increased activation of Nrf2 aims to reduce oxidative stress, thus contributing to tumor suppression [53]. Meanwhile, maintaining Nrf2 activation during the tumorigenesis stage may facilitate the transformation of dysplastic nodules into malignant cancer cells and make them resistant to treatment [53] and [54].

During the development of carcinoma, an increase in Nrf2 protein is associated with poor prognosis this website [48]. In our work, Nrf2 and Keap1 changes observed in both PL and HCC groups were in parallel with the changes on SOD activity, contributing to liver injury during hepatocarcinogenesis. Another interesting finding from our investigation was the significant reduction in the expression of HSP70 in liver tissue Vorinostat in vitro with advanced HCC. HSP70 has strong cytoprotective effects and functions as a molecular chaperone in protein folding, transport, and degradation [55]. HSP70 downregulation is associated with carcinogenesis of the oral epithelium, and is a marker of HCC [56]. HSP70 downregulation also correlates with poor prognosis in breast cancer [57], endometrial cancer [58], and pancreatic cancer [56]. Rohde et al. [59] reported that HSP70 is not a condition for the growth of tumor cells, but plays an important role in maintaining the deregulated tumor cell cycle. Chuma et al. [60] evaluated the expression of HSP70 in liver tissue with and without cancer, and identified HSP70 as a molecular marker of HCC progression. In conclusion, we have shown a multistage induction of HCC in rats through chronic and intermittent exposure to carcinogenic agents. Changes in SOD and NrF2 and TGF-1β stand out as markers of oxidative stress and cell damage in early HCC.